S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   160.67 (-0.59%)
MSFT   290.75 (-1.90%)
FB   302.03 (-2.16%)
GOOGL   2,556.40 (-2.28%)
AMZN   2,800.97 (-3.11%)
TSLA   928.67 (-0.14%)
NVDA   224.71 (-3.86%)
BABA   119.90 (-0.39%)
NIO   23.99 (-3.54%)
AMD   111.87 (-4.00%)
CGC   7.39 (-0.14%)
MU   81.13 (-2.19%)
GE   91.03 (-6.07%)
T   26.44 (+0.38%)
F   20.08 (-1.52%)
DIS   136.45 (-0.73%)
AMC   16.13 (-3.06%)
PFE   52.39 (+1.65%)
ACB   4.22 (-2.31%)
BA   203.75 (-0.22%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   160.67 (-0.59%)
MSFT   290.75 (-1.90%)
FB   302.03 (-2.16%)
GOOGL   2,556.40 (-2.28%)
AMZN   2,800.97 (-3.11%)
TSLA   928.67 (-0.14%)
NVDA   224.71 (-3.86%)
BABA   119.90 (-0.39%)
NIO   23.99 (-3.54%)
AMD   111.87 (-4.00%)
CGC   7.39 (-0.14%)
MU   81.13 (-2.19%)
GE   91.03 (-6.07%)
T   26.44 (+0.38%)
F   20.08 (-1.52%)
DIS   136.45 (-0.73%)
AMC   16.13 (-3.06%)
PFE   52.39 (+1.65%)
ACB   4.22 (-2.31%)
BA   203.75 (-0.22%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   160.67 (-0.59%)
MSFT   290.75 (-1.90%)
FB   302.03 (-2.16%)
GOOGL   2,556.40 (-2.28%)
AMZN   2,800.97 (-3.11%)
TSLA   928.67 (-0.14%)
NVDA   224.71 (-3.86%)
BABA   119.90 (-0.39%)
NIO   23.99 (-3.54%)
AMD   111.87 (-4.00%)
CGC   7.39 (-0.14%)
MU   81.13 (-2.19%)
GE   91.03 (-6.07%)
T   26.44 (+0.38%)
F   20.08 (-1.52%)
DIS   136.45 (-0.73%)
AMC   16.13 (-3.06%)
PFE   52.39 (+1.65%)
ACB   4.22 (-2.31%)
BA   203.75 (-0.22%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   160.67 (-0.59%)
MSFT   290.75 (-1.90%)
FB   302.03 (-2.16%)
GOOGL   2,556.40 (-2.28%)
AMZN   2,800.97 (-3.11%)
TSLA   928.67 (-0.14%)
NVDA   224.71 (-3.86%)
BABA   119.90 (-0.39%)
NIO   23.99 (-3.54%)
AMD   111.87 (-4.00%)
CGC   7.39 (-0.14%)
MU   81.13 (-2.19%)
GE   91.03 (-6.07%)
T   26.44 (+0.38%)
F   20.08 (-1.52%)
DIS   136.45 (-0.73%)
AMC   16.13 (-3.06%)
PFE   52.39 (+1.65%)
ACB   4.22 (-2.31%)
BA   203.75 (-0.22%)
NASDAQ:CWBR

CohBar Stock Forecast, Price & News

$0.30
+0.01 (+2.27%)
(As of 01/25/2022 03:33 PM ET)
Add
Compare
Today's Range
$0.29
$0.30
50-Day Range
$0.29
$0.59
52-Week Range
$0.25
$2.27
Volume
5,038 shs
Average Volume
731,193 shs
Market Capitalization
$25.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.52
30 days | 90 days | 365 days | Advanced Chart
Receive CWBR News and Ratings via Email

Sign-up to receive the latest news and ratings for CohBar and its competitors with MarketBeat's FREE daily newsletter.


CohBar logo

About CohBar

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CWBR
Fax
N/A
Employees
12
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.32 per share

Profitability

Net Income
$-16.26 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
59,379,000
Market Cap
$25.58 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
1/25/2022
Next Earnings (Estimated)
3/29/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.49 out of 5 stars

Medical Sector

139th out of 1,416 stocks

Pharmaceutical Preparations Industry

56th out of 684 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












CohBar (NASDAQ:CWBR) Frequently Asked Questions

Is CohBar a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CohBar in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CohBar stock.
View analyst ratings for CohBar
or view top-rated stocks.

How has CohBar's stock been impacted by COVID-19 (Coronavirus)?

CohBar's stock was trading at $1.76 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CWBR shares have decreased by 83.1% and is now trading at $0.2972.
View which stocks have been most impacted by COVID-19
.

Are investors shorting CohBar?

CohBar saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 1,000,000 shares, an increase of 50.9% from the December 15th total of 662,700 shares. Based on an average daily trading volume, of 1,880,000 shares, the days-to-cover ratio is currently 0.5 days.
View CohBar's Short Interest
.

When is CohBar's next earnings date?

CohBar is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022.
View our earnings forecast for CohBar
.

How were CohBar's earnings last quarter?

CohBar, Inc. (NASDAQ:CWBR) issued its quarterly earnings data on Monday, November, 15th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. During the same period last year, the business posted ($0.04) EPS.
View CohBar's earnings history
.

What price target have analysts set for CWBR?

4 brokers have issued twelve-month target prices for CohBar's shares. Their forecasts range from $2.50 to $6.00. On average, they expect CohBar's stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 1,161.8% from the stock's current price.
View analysts' price targets for CohBar
or view top-rated stocks among Wall Street analysts.

Who are CohBar's key executives?

CohBar's management team includes the following people:

What other stocks do shareholders of CohBar own?

What is CohBar's stock symbol?

CohBar trades on the NASDAQ under the ticker symbol "CWBR."

Who are CohBar's major shareholders?

CohBar's stock is owned by many different retail and institutional investors. Top institutional shareholders include Strategic Wealth Investment Group LLC (0.14%). Company insiders that own CohBar stock include Joseph J Sarret, Kenneth C Cundy and Misha Petkevich.
View institutional ownership trends for CohBar
.

Which institutional investors are buying CohBar stock?

CWBR stock was acquired by a variety of institutional investors in the last quarter, including Strategic Wealth Investment Group LLC. Company insiders that have bought CohBar stock in the last two years include Joseph J Sarret, and Misha Petkevich.
View insider buying and selling activity for CohBar
or or view top insider-buying stocks.

How do I buy shares of CohBar?

Shares of CWBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CohBar's stock price today?

One share of CWBR stock can currently be purchased for approximately $0.30.

How much money does CohBar make?

CohBar has a market capitalization of $25.58 million. The company earns $-16.26 million in net income (profit) each year or ($0.28) on an earnings per share basis.

How many employees does CohBar have?

CohBar employs 12 workers across the globe.

What is CohBar's official website?

The official website for CohBar is www.cohbar.com.

Where are CohBar's headquarters?

How can I contact CohBar?

CohBar's mailing address is 1455 Adams Drive Suite 2050, Menlo Park CA, 94025. The company can be reached via phone at (650) 446-7888 or via email at [email protected].


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.